← Leaderboards
Kevin D Houston
Rice University
$1,497,169
Attributed
$1,497,169
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $370K · FY2006–22$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,497,169 · 2
By mechanism
SC1$1,480,000 · 1
F32$17,169 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Adjuvant Therapy”
- Lawrence Corey · Fred Hutchinson Cancer Center$265,384,749
- Norman Wolmark · Nsabp Foundation, Inc.$252,082,455
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$105,968,129
- David Heimbrook · Leidos Biomedical Research, Inc.$59,661,099
- Dan H. Barouch · Fred Hutchinson Cancer Center$58,263,037
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$58,263,037
Research focus
Adjuvant TherapyAnimal ModelAgonistBaseBasic ScienceBreast Cancer CellBreast Cancer Cell LineBreast Cancer ProgressionCancer SubtypesCell Cycle RegulationCell ProliferationCellsClinically RelevantClinical ResearchClustered Regularly Interspaced Short Palindromic RepeatsDiagnosisDoseEpidermal Growth Factor ReceptorEsr1 GeneEstrogen Nuclear ReceptorEstrogen Receptor AlphaEstrogen ReceptorsEstrogensExperimental Study
Grant awards (5)
GPER1-dependent regulation of IGF-1R in tamoxifen treated breast cancer cells$370,000
SC1 · FY2022 · GM · contact PI
GPER1-dependent regulation of IGF-1R in tamoxifen treated breast cancer cells$370,000
SC1 · FY2021 · GM · contact PI
GPER1-dependent regulation of IGF-1R in tamoxifen treated breast cancer cells$370,000
SC1 · FY2020 · GM · contact PI
GPER1-dependent regulation of IGF-1R in tamoxifen treated breast cancer cells$370,000
SC1 · FY2019 · GM · contact PI
Regulation of TPP 1 (CLN2) Activity$17,169
F32 · FY2006 · GM · contact PI